Search Within

Joachim Yahalom

  1. "Eric Hedrick"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Hematologic Malignancies, Division of (8)
  4. Lymphoma (8)
  5. Radiation Oncology, Department of (8)
  6. Survivorship Research (8)

More Groups

People
  1. Andrew Zelenetz (8)
  2. Craig Moskowitz (8)
  3. Eric Hedrick (8)
  4. Stephen Nimer (8)
  5. Nancy Lyons (4)
  6. Tarun Kewalramani (4)

More People

Years
  1. 2001 (2)
  2. 2000 (3)
  3. 1999 (2)
  4. 1998 (1)
Publications
  1. Blood (7)
  2. Journal of Clinical Oncology (1)
Publishers
  1. American Society of Hematology (7)
  2. American Society of Clinical Oncology (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
    Meeting Abstract

    Kewalramani, T.; Zelenetz, A.; Bertino, J.; Donnelly, G.; Hedrick, E.; Noy, A.; O'connor, O.; Portlock, C.; Straus, D.; Yahalom, J.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model
    Journal Article

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Trippett, T.; Hedrick, E. E.; Filippa, D. A.; Louie, D.; Gonzales, M.; Walits, J.; Coady-Lyons, N.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • The outcome of patients with primary refractory Hodgkin's disease (HD) treated with high dose chemoradiotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hedrick, E. E.; Gonzalez, M.; Yahalom, J.
    Blood (2000)

    Fulltext@MSK | Save
  • Outcome of adult patients (pts) with chemosensitive (CS) relapsed or primary refractory Hodgkin's disease (HD) or aggressive NHL (NHL) after failure of autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Hedrick, E. E.; Malhotra, S.; Qin, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (2000)

    Fulltext@MSK | Save
  • High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: An intention-to-treat analysis
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Hedrick, E. E.; Donnelly, G. B.; Hunte, S.; Priovolos, A. C.; Qin, J.; Lyons, N. C.; Yahalom, J.; Nimer, S. D.; more...
    Blood (2000)

    Fulltext@MSK | Save
  • Persistent gallium avidity after second-line chemotherapy in Hodgkin's disease (HD) and intermediate-grade non-hodgkin's lymphoma (IGL) does not predict outcome following autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Donnelly, G. B.; Hedrick, E. E.; Kewalramani, T.; Satagopan, J. M.; Walits, J.; Yahalom, J.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (1999)

    Fulltext@MSK | Save
  • Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant- eligible patients with non-Hodgkin's lymphoma
    Journal Article

    Moskowitz, C. H.; Bertino, J. R.; Glassman, J. R.; Hedrick, E. E.; Hunte, S.; Coady-Lyons, N.; Agus, D. B.; Goy, A.; Jurcic, J.; Noy, A.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save
  • Safety and efficacy of high dose therapy and peripheral blood progenitor cell transplantation (HDT/PBPCT) in patients with non-Hodgkin's lymphoma (NHL) over the age of 55 years
    Meeting Abstract

    Hedrick, E. E.; Nimer, S. D.; Zelenetz, A. D.; Childs, B.; Frank, R.; Malhotra, S.; Coady-Lyons, N.; Yahalom, J.; Moskowitz, C. H.
    Blood (1998)

    Fulltext@MSK | Save